Companies
Calysta
Calysta pioneered methanotroph gas fermentation, producing the single-cell protein FeedKind from Methylococcus capsulatus with high nutritional value for aquaculture and pet diets.
- Country
- United States
Commercial
FDA GRAS
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| food-alt-protein | ✓ | ✓ | — | ✓ |
| livestock-aqua | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | $177.61M to $228M raised across multiple rounds | startupintros.com |
| Capacity | 20,000 tonnes per year at the Chongqing facility | calysta.com · feedkind.com |
| Regulatory approval | FeedKind approved for use in aquaculture feeds in China, the EU, Japan, and Thailand | calysta.com |
| Production site | Industrial-scale facility in Chongqing, China (operated by joint venture Calysseo) | agfundernews.com · calysta.com |
| Revenue | $710k for the joint venture Calysseo (unaudited 2025 results) medium confidence | agfundernews.com |
Independent sources: agfundernews.com · feedkind.com · startupintros.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Gas fermentation of food protein | food-alt-protein | Medium | → |
| Industrial single-cell protein for feed | livestock-aqua | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.